Jurcic, Joseph G <br/><br/>
What happened to anti-CD33 therapy for acute myeloid leukemia?  [electronic resource] 

 -  Current hematologic malignancy reports  Mar 2012 
 - 65-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1558-822X 
<br/><br/><label>Standard No.: </label>10.1007/s11899-011-0103-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminoglycosides--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antigens, CD--immunology<br/>Antigens, Differentiation, Myelomonocytic--immunology<br/>Antineoplastic Agents--therapeutic use<br/>Gemtuzumab<br/>Humans<br/>Leukemia, Myeloid, Acute--therapy<br/>Radioimmunotherapy--methods<br/>Sialic Acid Binding Ig-like Lectin 3